Avid Bioservices Inc (CDMO)

[pphmtoolong]

Bigbro1, the important thing is we have assessed Peregrine management's progress in moving Bavi to commercialization without more dilution than necessary. We like what we see.

We have judged Peregrine's readiness to spend money on Memorial Sloan Kettering's evaluation of Bavituximab as a huge positive signal.

We have judged AstraZeneca's interest in joint testing with Bavituximab as a huge positive signal.

We have judged Peregrine's success in moving the pivotal, Phase III NSCLC trial to full enrolment on schedule for Dec. 31, 2015 as a huge positive signal.

Other people may focus on other things. I'm sure we believe we are focused on more important things.

The fact that the share price shows more fear than greed tells me very little about Peregrine's future IMO. Just a good talking point for some.

We will soon know who is right. One group will make a lot of money; the other group won't. I like our odds.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul